<DOC>
	<DOC>NCT02654522</DOC>
	<brief_summary>The purpose of this study is to determine whether or not Recombinant DNA-based hyaluronidase (RDNAH/Hylenex recombinant), is safe and effective for dissolving hyaluronic acid (HA) dermal fillers.</brief_summary>
	<brief_title>The Use of a Recombinant DNA-based Hyaluronidase to Dissolve Fixed Amounts of Hyaluronic Acid Dermal Fillers</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Male or female 18 years of age or older Able to speak/write in the English language Negative Pregnancy Test on Day 1 Proposed injection site must be free of any active inflammation Pregnant or breast feeding History of keloid formation History of allergic reaction to hyaluronic acid dermal fillers, hyaluronidase, or any ingredients of the aforementioned products Active, uncontrolled inflammatory condition of any type History of allergic reaction to lidocaine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>